More importantly, independent assays for soluble immune checkpoints and common lung cancer tumor markers CEA, NSE, and CYFRA21‐1 showed all of the immune checkpoints except sPD‐1 had diagnostic potentials in the NSCLC detection. This evidence concerns the gene HOXD13 and neoplasm.